Cargando…

Coenzyme Q10 Supplementation Increases Removal of the ATXN3 Polyglutamine Repeat, Reducing Cerebellar Degeneration and Improving Motor Dysfunction in Murine Spinocerebellar Ataxia Type 3

Coenzyme Q10 (CoQ10), a well-known antioxidant, has been explored as a treatment in several neurodegenerative diseases, but its utility in spinocerebellar ataxia type 3 (SCA3) has not been explored. Herein, the protective effect of CoQ10 was examined using a transgenic mouse model of SCA3 onset. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yu-Ling, Chang, Jui-Chih, Sun, Hai-Lun, Cheng, Wen-Ling, Yen, Yu-Pei, Lin, Yong-Shiou, Chao, Yi-Chun, Liu, Ko-Hung, Huang, Ching-Shan, Liu, Kai-Li, Liu, Chin-San
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459709/ https://www.ncbi.nlm.nih.gov/pubmed/36079853 http://dx.doi.org/10.3390/nu14173593

Ejemplares similares

Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice
por: Toonen, Lodewijk J.A., et al.
Publicado: (2017)

CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3
por: Huang, Shang-Ran, et al.
Publicado: (2016)

The Mechanisms of Nuclear Proteotoxicity in Polyglutamine Spinocerebellar Ataxias
por: Lee, Davin, et al.
Publicado: (2020)

IGF-1 as a Potential Therapy for Spinocerebellar Ataxia Type 3
por: Lin, Yong-Shiou, et al.
Publicado: (2022)

The Truncated C-terminal Fragment of Mutant ATXN3 Disrupts Mitochondria Dynamics in Spinocerebellar Ataxia Type 3 Models
por: Hsu, Jung-Yu, et al.
Publicado: (2017)

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
por: Buijsen, Ronald A.M., et al.
Publicado: (2019)

Functional implications of paralog genes in polyglutamine spinocerebellar ataxias
por: Felício, Daniela, et al.
Publicado: (2023)

Unique degeneration signatures in the cerebellar cortex for spinocerebellar ataxias 2, 3, and 7
por: Hernandez-Castillo, Carlos R., et al.
Publicado: (2018)

ATTCT and ATTCC repeat expansions in the ATXN10 gene affect disease penetrance of spinocerebellar ataxia type 10
por: Morato Torres, C. Alejandra, et al.
Publicado: (2022)

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion
por: Niewiadomska-Cimicka, Anna, et al.
Publicado: (2020)

Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias
por: Afonso-Reis, Ricardo, et al.
Publicado: (2021)

Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias
por: Putka, Alexandra F., et al.
Publicado: (2023)

Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3
por: Koike, Yuka, et al.
Publicado: (2021)

Co‐occurrence of ATXN3 and ATXN2 repeat expansions in Chinese ataxia patients with slow saccades
por: Wu, Chao, et al.
Publicado: (2019)

Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1
por: Coffin, Stephanie L., et al.
Publicado: (2023)

Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1
por: Coffin, Stephanie L., et al.
Publicado: (2023)

Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways
por: Zeng, Li, et al.
Publicado: (2018)

Aberrant Cerebellar Circuitry in the Spinocerebellar Ataxias
por: Robinson, Katherine J., et al.
Publicado: (2020)

In Vitro Efficacy and Molecular Mechanism of Curcumin Analog in Pathological Regulation of Spinocerebellar Ataxia Type 3
por: Wu, Yu-Ling, et al.
Publicado: (2022)

Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells
por: Ou, Zhanhui, et al.
Publicado: (2016)

A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72‐ALS
por: Laffita‐Mesa, Jose Miguel, et al.
Publicado: (2020)

Ophthalmic Manifestations and Genetics of the Polyglutamine Autosomal Dominant Spinocerebellar Ataxias: A Review
por: Park, Jun Young, et al.
Publicado: (2020)

Effects of Repetitive Transcranial Magnetic Stimulation on Cerebellar Metabolism in Patients With Spinocerebellar Ataxia Type 3
por: Chen, Xin-Yuan, et al.
Publicado: (2022)

miRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3
por: Nobre, Rui Jorge, et al.
Publicado: (2022)

Cognitive Changes in the Spinocerebellar Ataxias Due to Expanded Polyglutamine Tracts: A Survey of the Literature
por: Lindsay, Evelyn, et al.
Publicado: (2017)

Detection Methods and Status of CAT Interruption of ATXN1 in Korean Patients With Spinocerebellar Ataxia Type 1
por: Jang, Ja-Hyun, et al.
Publicado: (2022)

Polyglutamine length-dependent toxicity from α1ACT in Drosophila models of spinocerebellar ataxia type 6
por: Tsou, Wei-Ling, et al.
Publicado: (2016)

Neurocognitive and cerebellar function in ADHD, autism and spinocerebellar ataxia
por: Cundari, Maurizio, et al.
Publicado: (2023)

New Perspectives of Gene Therapy on Polyglutamine Spinocerebellar Ataxias: From Molecular Targets to Novel Nanovectors
por: Borbolla-Jiménez, Fabiola V., et al.
Publicado: (2021)

Genetic Variance in the Spinocerebellar Ataxia Type 2 (ATXN2) Gene in Children with Severe Early Onset Obesity
por: Figueroa, Karla P., et al.
Publicado: (2009)

Cerebellar neuronal dysfunction accompanies early motor symptoms in spinocerebellar ataxia type 3
por: Mayoral-Palarz, Kristin, et al.
Publicado: (2022)

Spinocerebellar ataxia 7 (SCA7) in Indian population: predilection of ATXN7-CAG expansion mutation in an ethnic population
por: Faruq, Mohammed, et al.
Publicado: (2015)

Event-Related Desynchronization/Synchronization in Spinocerebellar Ataxia Type 3
por: Aoh, Yu, et al.
Publicado: (2019)

Altered H3 histone acetylation impairs high-fidelity DNA repair to promote cerebellar degeneration in spinocerebellar ataxia type 7
por: Switonski, Pawel M., et al.
Publicado: (2021)

Treatment with Caffeic Acid and Resveratrol Alleviates Oxidative Stress Induced Neurotoxicity in Cell and Drosophila Models of Spinocerebellar Ataxia Type3
por: Wu, Yu-Ling, et al.
Publicado: (2017)

Network Reconfiguration Among Cerebellar Visual, and Motor Regions Affects Movement Function in Spinocerebellar Ataxia Type 3
por: Chen, Hui, et al.
Publicado: (2022)

Therapeutic effects of engineered exosome-based miR-25 and miR-181a treatment in spinocerebellar ataxia type 3 mice by silencing ATXN3
por: Tang, Zhenchu, et al.
Publicado: (2023)

Cerebellar developmental deficits underlie neurodegenerative disorder spinocerebellar ataxia type 23
por: Smeets, Cleo J.L.M., et al.
Publicado: (2020)

Extra-Cerebellar Signs and Non-motor Features in Chinese Patients With Spinocerebellar Ataxia Type 3
por: Yuan, Xiaoqin, et al.
Publicado: (2019)

A model for the dynamics of expanded CAG repeat alleles: ATXN2 and ATXN3 as prototypes
por: Sena, Lucas Schenatto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ec6act91d2s9h3v85ucokojpqt